This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.

An automated fluid sample collector includes: a collection receptacle; an actuator; and a piercing element coupled to the actuator. An automated sample collection device includes: a sample receptacle; a needle that is able to extend into the sample receptacle; an actuator coupled to the needle such that the actuator is able to extend and retract the needle; and a fluid chip coupled to the sample receptacle, the fluid chip able to accommodate an amount of collected fluid. An automated method of collecting a fluid sample includes: activating a pump associated with a finger retention element in order to add fluid to the finger retention element; extending an actuator associated with a piercing element; opening a pinch valve; activating a collection pump; deactivating the collection pump; closing the pinch valve; and releasing fluid from the finger retention element.

The present invention provides methods of calibrating a fluidic device useful for detecting an analyte of interest in a bodily fluid. The invention also provides methods for assessing the reliability of an assay for an analyte in a bodily fluid with the use of a fluidic device. Another aspect of the invention is a method for performing a trend analysis on the concentration of an analyte in a subject using a fluidic device.

A method for assessing a user's health comprises receiving a first biometric parameter from the user's wearable device and determining whether the first biometric parameter was collected for a time period satisfying a time threshold. The method comprises, upon the time threshold being satisfied, calculating a second biometric parameter based on the first biometric parameter and/or user's health attributes provided by the user. The method comprises determining a health score for the user based on the health score, the first biometric parameter, and/or the second biometric parameter. The method further comprises transmitting and populating a user interface associated with the user with the health score, the first biometric parameter, and/or the second biometric parameter.

Provided are a blood test support device, a blood test support system, a blood test support method, and a program that can reduce a burden on a medical examinee and obtain highly accurate test results. The blood test support device includes an information acquisition unit that acquires an order for a blood test kit from a medical examinee; a storage unit that stores the medical examinee and an identification number given to the blood test kit in association with each other; a processing unit that calculates a recommended date and time at which blood collection is performed using the blood test kit to which the identification number is given; and an information output unit that outputs the identification number of the blood test kit and the recommended date and time in placing the order from the medical examinee.

Provided are a sample inspection plan management device, a sample inspection plan management system, a sample inspection plan management method, and a program capable of managing a sample inspection implemented by a doctor as a starting point. There is provided a sample inspection plan management device (12) that manages a sample inspection plan in a case where a sample inspection is implemented by using a sample inspection kit acquirable by a medical examinee outside a hospital. The device includes an inspection plan acquisition unit (30A) that acquires a sample inspection plan created by a doctor via a system of the hospital, a delivery information output unit (32A) that outputs delivery information including a delivery destination of the sample inspection kit based on the sample inspection plan, and an inspection result acquisition unit (30B) that acquires an inspection result of a sample collected by using the sample inspection kit delivered based on the delivery information via a system of an inspection institution that implements the sample inspection by retrieving the sample inspection kit.

Devices are provided to automatically inject drugs or other payloads into or beneath skin. These devices include an injector configured to drive a hollow needle into the skin and subsequently to deliver the payload through the hollow needle. Applied suction acts to draw blood from the puncture formed in the skin through the hollow needle, into the device, and to a sensor, blood storage element, or other payload. In some examples, the blood is drawn through the hollow needle when the hollow needle is penetrating the skin. In some examples, these devices are additionally configured to retract the hollow needle from the skin and/or to perform some other functions. These devices can be wearable and configured to automatically access blood or deliver a payload into skin, for example, to operate at one or more points in time while a wearer of a device is sleeping.

A system is provided for monitoring analyte in a host, including a continuous analyte sensor that produces a data stream indicative of a host's analyte concentration and a device that receives and records data from the data stream from the continuous analyte sensor. In one embodiment, the device includes a single point analyte monitor, from which it obtains an analyte value, and is configured to display only single point analyte measurement values, and not any analyte measurement values associated with data received from the continuous analyte sensor. Instead, data received from the continuous analyte sensor is used to provide alarms to the user when the analyte concentration and/or the rate of change of analyte concentration, as measured by the continuous analyte sensor, is above or below a predetermined range. Data received from the continuous analyte sensor may also be used to prompt the diabetic or caregiver to take certain actions, such as to perform another single point blood glucose measurement. In another embodiment, the device provides for toggling between two modes, with one mode that allows for display of glucose concentration values associated with the continuous glucose sensor and a second mode that prevents the display of glucose concentration values associated with the continuous glucose sensor.

An optical fluid measurement element includes: an emitter that generates an optical output; an absorber that measures an optical input; and a fluid flow pathway, where the optical output of the emitter passes through the fluid flow pathway and is received as the optical input to the absorber after passing through the portion of the fluid flow pathway. An automated method of measuring fluid volume using an optical fluid measurement element includes: activating an emitter; capturing data from an optical sensor; detecting a leading edge of fluid travelling along a flow pathway; starting a counter when the leading edge is detected; and calculating a volume based on a value of the counter. An automated method of measuring fluid attributes along a flow pathway. The method includes: activating an optical emitter; receiving a signal from an optical sensor; and processing the received signal to determine at least one fluid attribute.

Real time glucose monitoring is the only product of its kind that has the capability of adapting to an ICU's already existing blood monitoring system to communicate real-time blood sugar readings to an ICU monitor. This unprecedented device is uniquely designed with durable, high-quality materials to ensure long-term sustainability and employs advanced Bluetooth technology that works in complement with a patch that manages insulin drips with real time glucose levels.